Reference
Medicines and Healthcare products Regulatory Agency. Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision Internet Document : 15 Mar 2022. Available from: URL: https://www.gov.uk/drug-safety-update/amiodarone-cordarone-x-reminder-of-risks-of-treatment-and-need-for-patient-monitoring-and-supervision
Rights and permissions
About this article
Cite this article
Reminder to monitor for adverse lung, liver and thyroid changes with amiodarone treatment. Reactions Weekly 1899, 4 (2022). https://doi.org/10.1007/s40278-022-11978-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-11978-y